Weekly updateCompaniesRecruiting servicePost a job
GentiBio

GentiBio

    Company info:

  • 1-50
  • 2020
  • Boston, MA
  • 100-500M


gentibio.com

linkedin.com


Claim company profile

About company:

GentiBio is developing engineered regulatory T cells (Tregs). Tregs are the body’s natural means for keeping the immune system in balance. Tregs suppress potentially pathogenic immune activation and promote tissue repair; however, Treg activity is lost in some diseases. GentiBio is using their modular engineering platform to create optimized Tregs as powerful and tailored therapeutics for autoimmune and inflammatory diseases.

GentiBio’s engineered Tregs overcome the limitations of endogenous, sorted Tregs by transforming the cells with superior phenotypes including resistance to inflammation, increased potency and scalable manufacturing. GentiBio’s most advanced product is GNTI-122, an autologous engineered Tregs product to treat type 1 diabetes.

Jobs:

GentiBio
Associate Director/Director, Discovery Immunology
Boston, MA|50 days ago
GentiBio
Scientist/Senior Scientist, Protein Engineering
Boston, MA|55 days ago
GentiBio
Scientist/Senior Scientist, Discovery Immunology
Boston, MA|63 days ago
GentiBio
Associate Scientist/Senior Associate Scientist, Discovery Im...
Boston, MA|63 days ago
GentiBio
Senior Director, Program Management
Boston, MA|70 days ago
GentiBio
Senior Medical Director
Boston, MA|83 days ago
GentiBio
Scientist, Genome Editing
Boston, MA|100+ days ago


© 2022 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com